Projected Income Statement: DexCom, Inc.

Forecast Balance Sheet: DexCom, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 650 1,328 1,868 696 323 -370 -1,248 -2,354
Change - 104.31% 40.66% -62.74% -53.59% -214.48% -237.3% -88.62%
Announcement Date 10/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: DexCom, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 389.2 364.8 236.6 358.8 363.5 372.2 385.5 411.4
Change - -6.27% -35.14% 51.65% 1.31% 2.38% 3.59% 6.71%
Free Cash Flow (FCF) 1 53.3 305 511.9 630.7 1,077 993.5 1,243 1,517
Change - 472.23% 67.84% 23.21% 70.79% -7.77% 25.09% 22.03%
Announcement Date 10/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: DexCom, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.31% 25.83% 28.01% 27.4% 28.93% 31.38% 32.84% 34.13%
EBIT Margin (%) 15.14% 16.67% 19.84% 18.77% 20.79% 23.2% 24.66% 26.41%
EBT Margin (%) 7.1% 13.43% 19.61% 17.58% 23.35% 24.04% 25.33% 26.3%
Net margin (%) 6.32% 11.73% 14.95% 14.29% 17.94% 18.42% 19.86% 21.13%
FCF margin (%) 2.18% 10.48% 14.13% 15.64% 23.11% 19.01% 21.32% 23.24%
FCF / Net Income (%) 34.45% 89.39% 94.53% 109.46% 128.81% 103.21% 107.34% 110.02%

Profitability

        
ROA 5.83% 6.78% 9.29% 9.2% 13.04% 14.11% 15.3% 15.54%
ROE 13.08% 16.77% 25.78% 27.63% 34.16% 32.91% 33.58% 31.28%

Financial Health

        
Leverage (Debt/EBITDA) 1.38x 1.77x 1.84x 0.63x 0.24x - - -
Debt / Free cash flow 12.2x 4.35x 3.65x 1.1x 0.3x - - -

Capital Intensity

        
CAPEX / Current Assets (%) 15.9% 12.54% 6.53% 8.9% 7.8% 7.12% 6.61% 6.3%
CAPEX / EBITDA (%) 82.34% 48.54% 23.32% 32.47% 26.95% 22.7% 20.14% 18.47%
CAPEX / FCF (%) 730.21% 119.61% 46.22% 56.89% 33.74% 37.46% 31.02% 27.13%

Items per share

        
Cash flow per share 1 1.105 1.566 1.759 2.398 3.553 4.059 4.149 -
Change - 41.7% 12.33% 36.3% 48.19% 14.25% 2.21% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 5.803 5.518 5.367 5.164 7.136 6.742 6.935 9.6
Change - -4.9% -2.74% -3.8% 38.2% -5.53% 2.87% 38.42%
EPS 1 0.3875 0.82 1.3 1.42 2.09 2.448 2.921 3.51
Change - 111.61% 58.54% 9.23% 47.18% 17.12% 19.32% 20.19%
Nbr of stocks (in thousands) 387,688 386,258 386,374 390,595 390,016 385,873 385,873 385,873
Announcement Date 10/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E Ratio 30.3x 25.4x
PBR 11x 10.7x
EV / Sales 5.41x 4.7x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
74.22USD
Average target price
85.21USD
Spread / Average Target
+14.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock
  4. Financials DexCom, Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!